- Department of Neurology
- Mitochondrial Program
St. Petersburg Pediatric Medical Academy, 1984
St. Petersburg Pediatric Medical Academy, 07/84 to 06/85
University of Massachusetts Medical Center, 1993 to 1995
New England Medical Center, 1995 to 1998
Pediatrics, Child Neurology
Irina A. Anselm, MD, is Director of the Mitochondrial Program and Co-Director of the Neurometabolic Program at Boston Children’s Hospital. A pediatric neurologist with special interest in genetics and hereditary disorders, she cares for children with neurometabolic, neurodegenerative, and mitochondrial disorders. Her research focuses on the genetics, diagnosis, and management of these disorders, which range from mild to devastating. She is the Principal Investigator of a study investigating the use of experimental drug dichloroacetate (DCA) as a treatment for chronic elevation of blood lactate levels resulting from mitochondrial disorders. Major publications include 20 original reports in peer-reviewed journals and 4 chapters, and she is a reviewer for the Journal of Pediatric Neurology, Current Pediatric Reviews, and the Journal of Child Neurology.